Physician profile
Allison E Gullo
NPI 1093921660
$617.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $112 · 2021: $169 · 2022: $16.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $170.40 | 2019-2021 | |
| Daiichi Sankyo INC. | $143.79 | 2019 | |
| Grt US Holding, INC. | $116.25 | 2021 | |
| Amgen INC. | $47.25 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $32.21 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.73 | 2020 | |
| Tersera Therapeutics LLC | $22.20 | 2019 | |
| Mdd US Operations, LLC | $18.60 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.99 | 2020 | |
| Assertio Therapeutics, INC. | $13.06 | 2019 | |
| Si-Bone, INC. | $12.56 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Gullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.